EFFICACY STUDIES ON A CANARYPOX-RABIES RECOMBINANT VIRUS

被引：129
|
作者：
TAYLOR, J
TRIMARCHI, C
WEINBERG, R
LANGUET, B
GUILLEMIN, F
DESMETTRE, P
PAOLETTI, E
机构：
[1] VIROGENET CORP,465 JORDAN RD,RENSSELAER TECHNOL PK,TROY,NY 12180
[2] NEW YORK STATE DEPT HLTH,WADSWORTH CTR LABS & RES,ALBANY,NY 12201
[3] RHONE MERIEUX,F-69007 LYONS,FRANCE
来源：
VACCINE | 1991年 / 9卷 / 03期
关键词：
RECOMBINANT; CANARYPOX; RABIES; FOWLPOX; VACCINIA;
D O I：
10.1016/0264-410X(91)90152-V
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Recombinant avipox viruses have been developed expressing the rabies glycoprotein gene. A fowlpox-rabies recombinant has previously been shown to be protective against live rabies virus challenge in a number of non-avian species1. This report describes the development of a canarypox-rabies recombinant. A comparison is made of the protective efficacy of this recombinant with other pox-rabies recombinants.
引用
收藏
页码：190 / 193
页数：4
相关论文
共 50 条
  • [21] Studies on antigenic and genomic properties of Brazilian rabies virus isolates
    Schaefer, R
    Batista, HBR
    Franco, AC
    Rijsewijk, FAM
    Roehe, PM
    VETERINARY MICROBIOLOGY, 2005, 107 (3-4) : 161 - 170
  • [22] REVERSION TO VIRULENCE AND EFFICACY OF AN ATTENUATED CANARYPOX VACCINE IN HAWAI'I 'AMAKIHI (HEMIGNATHUS VIRENS)
    Atkinson, Carter T.
    Wiegand, Kimberly C.
    Triglia, Dennis
    Jarvi, Susan I.
    JOURNAL OF ZOO AND WILDLIFE MEDICINE, 2012, 43 (04) : 808 - 819
  • [23] First North American field release of a vaccinia-rabies glycoprotein recombinant virus
    Hanlon, CA
    Niezgoda, M
    Hamir, AN
    Schumacher, C
    Koprowski, H
    Rupprecht, CE
    JOURNAL OF WILDLIFE DISEASES, 1998, 34 (02) : 228 - 239
  • [24] Immunogenicity of a recombinant lumpy skin disease virus (neethling vaccine strain) expressing the rabies virus glycoprotein in cattle
    Aspden, K
    van Dijk, AA
    Bingham, J
    Cox, D
    Passmore, JA
    Williamson, AL
    VACCINE, 2002, 20 (21-22) : 2693 - 2701
  • [25] SAFETY, IMMUNOGENICITY, AND EFFICACY OF INTRAMUSCULAR AND ORAL DELIVERY OF ERA-G333 RECOMBINANT RABIES VIRUS VACCINE TO BIG BROWN BATS (EPTESICUS FUSCUS)
    Gilbert, Amy T.
    Wu, Xianfu
    Jackson, Felix R.
    Franka, Richard
    McCracken, Gary F.
    Rupprecht, Charles E.
    JOURNAL OF WILDLIFE DISEASES, 2020, 56 (03) : 620 - 630
  • [26] Molecular Docking Studies with Rabies Virus Glycoprotein to Design Viral Therapeutics
    Tomar, N. R.
    Singh, V.
    Marla, S. S.
    Chandra, R.
    Kumar, R.
    Kumar, A.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 72 (04) : 486 - 490
  • [27] Expression of functional recombinant rabies virus glycoprotein in Drosophila melanogaster S2 cells
    Adriana Y Yokomizo
    Soraia AC Jorge
    Renato M Astray
    Mariza AG Santos
    Irene Fernandes
    Orlando G Ribeiro
    Denise SPQ Horton
    Aldo Tonso
    Carlos A Pereira
    Microbial Cell Factories, 5 (Suppl 1)
  • [28] Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper
    Wang, Xijun
    Feng, Na
    Ge, Jinying
    Shuai, Lei
    Peng, Liyan
    Gao, Yuwei
    Yang, Songtao
    Xia, Xianzhu
    Bu, Zhigao
    VACCINE, 2012, 30 (34) : 5067 - 5072
  • [29] Rabies virus receptors
    Monique Lafon
    BMC Proceedings, 2 (Suppl 1)
  • [30] Inactivation of rabies virus
    Wu, Guanghui
    Selden, David
    Fooks, Anthony R.
    Banyard, Ashley
    JOURNAL OF VIROLOGICAL METHODS, 2017, 243 : 109 - 112
12345